Navigation Links
DNDi is awarded USD 17.3 million from UNITAID to spur development and delivery of child-adapted ARVs
Date:12/11/2012

[Geneva, Switzerland, 11 December 2012] The Drugs for Neglected Diseases initiative welcomes the announcement by UNITAID to grant up to USD 17.3 million to the organization for its paediatric HIV programme. The grant, to be disbursed over three years, will enable DNDi and partners to build on the advances made in the field of paediatric HIV to date, and drive specific research and development to deliver child-adapted ARV formulations that do not require refrigeration, are easy-to-administer and palatable, with simplified dosing, and which can be given to children co-infected with tuberculosis.

'This support from UNITAID is an encouraging sign that DNDi and our partners are on the right path, and we will stay focused in our efforts to ensure that adapted treatments reach the kids that need them', said Dr Bernard Pcoul, Executive Director of DNDi. 'Timely delivery, adoption, and uptake will be key to saving the lives of the youngest children with HIV/AIDS', he added.

DNDi entered into the field of paediatric HIV in 2011 and, earlier this year, announced a partnership agreement with the Indian drug manufacturer Cipla to develop adapted 4-in-1 ARV formulations for children with HIV/AIDS under three years of age.


'/>"/>

Contact: Violaine Dallenbach
vdallenbach@dndi.org
41-794-241-474
Drugs for Neglected Diseases Initiative
Source:Eurekalert

Page: 1

Related medicine news :

1. Speech-language researcher awarded top honors
2. Boston Medical Center awarded elite distinction as a 2012 Leapfrog Top Hospital
3. Scripps Florida scientist awarded $2.5 million to study inner workings of memory formation
4. LSUHSCs Tilton awarded prestigious Hower Award
5. Vijay Tiwari awarded prestigious grant to study how cancer cells transform to become invasive
6. Kessler Foundation scientists awarded New Jersey grants for brain injury research
7. Einstein-Montefiore scientists awarded 2 NCI Provocative Questions grants
8. Illy Trieste Science Prize: Yuk Ming Dennis Lo awarded for non-invasive prenatal diagnosis
9. Nearly $50 million in research funding awarded by NSF
10. Cedars-Sinai Heart Institute awarded $1.3 million to study cardiac stem cells
11. Weill Cornell awarded $1.8 million for translational blood cancer research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
Breaking Medicine Technology: